Yoko Zaitsu
Impact in
-
- Cancer Immunotherapy and Biomarkers
Papers in
- Co-authors
- Eiji Oki (24 shared papers)Koji Ando (15 shared papers)Yoshihiko Maehara (15 shared papers)Yuichiro Nakashima (14 shared papers)Yasue Kimura (10 shared papers)Hiroshi Saeki (5 shared papers)Hiroshi Saeki (10 shared papers)Yasuo Tsuda (9 shared papers)
- Journals
- International Journal of Clinical Oncology (4 papers)Surgery Today (2 papers)Oncology (2 papers)Anticancer Research (1 paper)Esophagus (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Yoko Zaitsu
28 papers receiving 253 citations
Peers
Comparison fields: 5 of 49
- Oncology 126
- Geriatrics and Gerontology 11
- Gastroenterology 15
- Surgery 107
- Pulmonary and Respiratory Medicine 74
Countries citing papers authored by Yoko Zaitsu
This map shows the geographic impact of Yoko Zaitsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Zaitsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Zaitsu more than expected).
Fields of papers citing papers by Yoko Zaitsu
This network shows the impact of papers produced by Yoko Zaitsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Zaitsu. The network helps show where Yoko Zaitsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yoko Zaitsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 37 | |
| 2 | 2015 | 29 | |
| 3 | 2014 | 29 | |
| 4 | 2019 | 27 | |
| 5 | 2020 | 19 | |
| 6 | 2013 | 11 | |
| 7 | Significance of accurate human epidermal growth factor receptor-2 (HER2) evaluation as a new biomarker in gastric cancer. | 2014 | 9 |
| 8 | 2014 | 9 | |
| 9 | 2015 | 9 | |
| 10 | 2020 | 8 | |
| 11 | Hyperthermia combined with chemotherapy for patients with residual or recurrent oesophageal cancer after definitive chemoradiotherapy. | 2015 | 8 |
| 12 | Conversion to Neuroendocrine Carcinoma from Squamous Cell Carcinoma of the Esophagus After Definitive Chemoradiotherapy. | 2016 | 8 |
| 13 | 2015 | 7 | |
| 14 | 2019 | 7 | |
| 15 | 2015 | 6 | |
| 16 | 2024 | 5 | |
| 17 | 2020 | 5 | |
| 18 | 2015 | 5 | |
| 19 | 2014 | 4 | |
| 20 | 2014 | 3 |
About Yoko Zaitsu
Yoko Zaitsu is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Epidemiology, having authored 30 papers that have together received 257 indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (6 papers), Colorectal Cancer Treatments and Studies (6 papers), Esophageal Cancer Research and Treatment (4 papers), Gastric Cancer Management and Outcomes (4 papers), Colorectal and Anal Carcinomas (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer Cells and Metastasis (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Oncology (126 citations), Geriatrics and Gerontology (11 citations), Gastroenterology (15 citations), Surgery (107 citations) and Pulmonary and Respiratory Medicine (74 citations). Yoko Zaitsu has collaborated with scholars based in Japan and United States. Frequent co-authors include Eiji Oki, Koji Ando, Yoshihiko Maehara, Yuichiro Nakashima, Yasue Kimura, Hiroshi Saeki, Hiroshi Saeki, Yasuo Tsuda, Qingjiang Hu and Yuichi Hisamatsu. Their work appears in journals such as International Journal of Clinical Oncology, Surgery Today, Oncology, Anticancer Research and Esophagus.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.